Group motivational intervention in overweight/obese patients in primary prevention of cardiovascular disease in the primary healthcare area
1 Medicina, Area Básica Salud Florida Sud, Parc dels Ocellets, L'Hospitalet del Llobregat, Barcelona, Spain
2 Departamento de Medicina, Hospital de Igualada, Barcelona, Spain
3 Institut Català de Ciències Cardiovasculars, Centre superior d'Investigacions Científiques, Barcelona, Spain
4 Departament mèdic, Solvay Pharma, Barcelona, Spain
5 Unitat de Salut Mental Collblanc, L'Hospitalet del Llobregat, Barcelona, Spain
6 Laboratorio Clínico L'Hospitalet. Institut Català de la Salut, Centre Assistència Primària Just Oliveras, L'Hospitalet de Llobregat, Barcelona, Spain
7 Area bàsica de la Salut Rio de Janeiro, Barcelona, Spain
8 Hospital de Viladecans, Viladecans, Barcelona, Spain
BMC Family Practice 2010, 11:23 doi:10.1186/1471-2296-11-23Published: 18 March 2010
The global mortality caused by cardiovascular disease increases with weight. The Framingham study showed that obesity is a cardiovascular risk factor independent of other risks such as type 2 diabetes mellitus, dyslipidemia and smoking. Moreover, the main problem in the management of weight-loss is its maintenance, if it is achieved. We have designed a study to determine whether a group motivational intervention, together with current clinical practice, is more efficient than the latter alone in the treatment of overweight and obesity, for initial weight loss and essentially to achieve maintenance of the weight achieved; and, secondly, to know if this intervention is more effective for reducing cardiovascular risk factors associated with overweight and obesity.
This 26-month follow up multi-centre trial, will include 1200 overweight/obese patients. Random assignment of the intervention by Basic Health Areas (BHA): two geographically separate groups have been created, one of which receives group motivational intervention (group intervention), delivered by a nurse trained by an expert phsychologist, in 32 group sessions, 1 to 12 fortnightly, and 13 to 32, monthly, on top of their standard program of diet, exercise, and the other (control group), receiving the usual follow up, with regular visits every 3 months.
By addressing currently unanswered questions regarding the maintenance in weight loss in obesity/overweight, upon the expected completion of participant follow-up in 2012, the IMOAP trial should document, for the first time, the benefits of a motivational intervention as a treatment tool of weight loss in a primary care setting.
ClinicalTrials.gov Identifier: NCT01006213